Evidence map›Paper›PMID 36672434›Full record

ReviewCancers2023

Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management.

Sukanya Pati, Wadeed Irfan, Ahmad Jameel, Shahid Ahmed, Rabia K Shahid

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07655739 (Temporal Changes in Fractalkine), which is not on this map. Cited by 377 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
377citing papers in PubMed, 10 pooled it
88.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07655739 completednot on this mapstarted 2025, after this paper: background citation

Temporal Changes in Fractalkine (CX3CL1) Levels Following Sleeve Gastrectomy and Their Association With Weight Loss: A Prospective Study

Typeobservational_patient_registrySponsorMehmet Buğra BozanRan2025 to 2026Enrolled40ConditionsObesity & Overweight
3 · Its place in the literature

Who cites it

377 citing papers in PubMed, 10 syntheses or guidelines pooled it, 576 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Life Course Trajectories of Body Mass Index and Risk of Cancer in Adulthood: Systematic Review and Meta-Analysis.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Obesity Promotes Lung Carcinogenesis Through Airway Immune Dysfunction.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026
    Article
  20. Article

317 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sukanya PatiCollege of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Wadeed IrfanRoyal College of Surgeon, Dublin 2, Ireland.ORCID 0000-0003-1508-9741
Ahmad JameelCollege of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
Shahid AhmedCollege of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.ORCID 0000-0002-2099-698X
Rabia K ShahidCollege of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
University of Saskatchewan · CARoyal College of Surgeons in Ireland · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObesity or excess body fat is a major global health challenge that has not only been associated with diabetes mellitus and cardiovascular disease but is also a major risk factor for the development of and mortality related to a subgroup of cancer. This review focuses on epidemiology, the relationship between obesity and the risk associated with the development and recurrence of cancer and the management of obesity.

methodsA literature search using PubMed and Google Scholar was performed and the keywords 'obesity' and cancer' were used. The search was limited to research papers published in English prior to September 2022 and focused on studies that investigated epidemiology, the pathogenesis of cancer, cancer incidence and the risk of recurrence, and the management of obesity.

resultsAbout 4-8% of all cancers are attributed to obesity. Obesity is a risk factor for several major cancers, including post-menopausal breast, colorectal, endometrial, kidney, esophageal, pancreatic, liver, and gallbladder cancer. Excess body fat results in an approximately 17% increased risk of cancer-specific mortality. The relationship between obesity and the risk associated with the development of cancer and its recurrence is not fully understood and involves altered fatty acid metabolism, extracellular matrix remodeling, the secretion of adipokines and anabolic and sex hormones, immune dysregulation, and chronic inflammation. Obesity may also increase treatment-related adverse effects and influence treatment decisions regarding specific types of cancer therapy. Structured exercise in combination with dietary support and behavior therapy are effective interventions. Treatment with glucagon-like peptide-1 analogues and bariatric surgery result in more rapid weight loss and can be considered in selected cancer survivors.

conclusionsObesity increases cancer risk and mortality. Weight-reducing strategies in obesity-associated cancers are important interventions as a key component of cancer care. Future studies are warranted to further elucidate the complex relationship between obesity and cancer with the identification of targets for effective interventions.

Indexed as

body mass indexcancercancer outcomescancer riskepidemiologymalignancyobesityoverweighttreatment

Identifiers

PMID36672434
PMCPMC9857053
OpenAlexW4316039477

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.